Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytokinetics, Inc.
Data from heart-failure drug-discovery program presented at AHA meeting
December 7th, 2004
Cytokinetics, Inc., (CYTK) announced the presentation of nonclinical research data relating to its congestive heart failure drug-discovery program. The presentation, entitled "The Cardiac Myosin Activator, CK1122534, Increases Contractility in Adult Cardiac Myocytes but Does Not Affect the Calcium Transient or Depend on Second Messenger Signaling," was presented at the 2004 scientific sessions of the American Heart Association (AHA) in New Orleans, Louisiana. The scientific results presented were the first data from this research program to be communicated in a public scientific forum and are specifically related to an experimental compound,...
Source: Cardiovascular Business Week (2004-12-07)
|
